LINC01890

Across TCGA pan-cancer cohorts, LINC01890 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01890 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01890 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01890 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, READ, and KICH are the cancer types where LINC01890 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.775	0.595	.005	69	view →
READ	OS	Tertile	III,IV	0.462	0.913	<.001	63	view →
KICH	DFS	Tertile	All	0.296	0.889	.002	48	view →
COAD	OS	Tertile	IV	0.082	0.659	<.001	45	view →
SKCM	OS	Tertile	All	0.501	0.304	<.001	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
THCA	DFS	Tertile	III,IV	0.661	0.853	.004	24	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	18	view →
ESCA	DFS	Tertile	All	0.420	0.795	.038	18	view →
LIHC	DFS	Tertile	II,III,IV	0.185	0.491	.003	9	view →
LGG	OS	Tertile	All	0.837	0.905	.028	6	view →
STAD	OS	Median	IV	0.561	0.197	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01890–HNSC (OS)

Open the HNSC breakdown →